Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer

Published:2015-03-16 Issue:3 Volume:10 Page:e0119614
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boerner Julie L.,Nechiporchik Nicole,Mueller Kelly L.,Polin Lisa,Heilbrun Lance,Boerner Scott A.,Zoratti Gina L.,Stark Karri,LoRusso Patricia M.,Burger Angelika

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Basal carcinoma of the breast revisited: an old entity with new interpretations;E Korsching;Journal of Clinical Pathology,2008

2. Treatment options for patients with triple-negative breast cancer;R Santana-Davila;J Hematol Oncol,2010

3. Triple-negative breast cancer;RD Chacon;Breast Cancer Res,2010

4. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair;LM Starita;Current Opinion in Cell Biology,2003

5. Clinical implications for BRCA gene mutation in breast cancer;J Xu;Molecular Biology Reports,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors;Journal of Hematology & Oncology;2024-01-04

2. NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors;Cancer Research Communications;2023-06-26

3. BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity;Frontiers in Genetics;2023-02-16

4. PARP Inhibitors and Proteins Interacting with SLX4;Cancers;2023-02-03

5. The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy;Pharmaceuticals;2023-01-09